Summary
In the present study, the levels of the growth-promoting hormones, somatomedins, were analysed in tumour cyst fluid, CSF, and tumour cytosol, collected from 22 unselected patients with intracranial tumours. All samples contained somatomedin activity. 5/7 CSF samples, taken from patients with tumour mass visible on CT, showed elevated concentrations. 6/9 cyst fluid samples, taken from patients with glioma were elevated compared with normal serum somatomedin levels. Tumour cytosol, taken from 7 patients with malignant glioma contained somatomedins in an elevated level compared with values previously analysed from normal adult brains. These preliminary findings demonstrate for the first time the presence of somatomedins in brain tumours and suggest the use of somatomedins as a possible brain tumour marker.
Similar content being viewed by others
References
Blatt J, White C, Dienes S, et al (1984) Production of an insulin-like growth factor by osteosarcoma. Biochem Biophys Res Commun 123: 373–376
Betsholtz C, Heldin CH, Nistér M, et al (1983) Synthesis of a PDGF-like growth factor in human glioma and sarcoma cells suggests the expression of the cellular homologue of the transforming protein of simian sarcoma virus. Biochem Biophys Res Commun 117: 176–182
Carlsson-Skwirut C, Jörnvall H, Holmgren A, et al (1986) Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain. FEBS lett 201: 46–50
Larco JE de, Todaro GJ (1978) A human fibrosarcoma cell line producing multiplication stimulating activity (MSA)-related peptides. Nature 272: 356–358
Larco JE de, Todaro GJ (1978) Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci 75: 4001–4005
Gronowitz JS, Källander CFR, Hagberg H, Persson L (1984) Deoxythymidine-kinase in cerebrospinal fluid: a new potential “marker” for brain tumours. Acta Neurochir (Wien) 73: 1–12
Hall K, Sara VR (1983) Growth and somatomedins. In: Aurbach GD (ed) Vitamins and hormones, Vol 40. New York, pp 175–218
Heldin CH, Westermark B, Wasteson Å (1980) Chemical and biological properties of a growth factor human cultured osteosarcoma cells resemblance with platelet derived growth factor. J Cell Physiol 105: 235–246
Heldin CH, Westermark B (1984) Growth factors: Mechanism of action and relation to oncogenes. Cell 37: 9–20
Holst H von, Sara VR (1985) Increased levels of somatomedins in human lumbar and central cerebrospinal fluid after subarachnoid haemorrhage. Acta Neurochir (Wien) 78: 157–160
Johnsson A, Heldin CH, Wasteson Å, et al (1984) The C-sis gene encodes a precursor of the B-chain of platelet-derived growth factor. EMBO J 3: 921–928
Kalb VF Jr, Bern-Lohr R (1977) A new spectrophotomeric assay for protein in ell extracts. Anal Biochem 82: 362–371
Kampen EJ van, Zijlstra WG (1961) Standardization of hemiglobinmetry. II Hemiglobincyanide method. Acta Clin Chem 6: 538
Knauer DJ, Jyer AP, Banerjee MR, et al (1980) Identification of somatomedin-like polypeptides produced by mammary tumours of BALB/c mice. Cancer Res 40: 4368–4372
Minuto F, Monte P del, Barreca A, et al (1986) Evidence for an increased somatomedin-C/Insulin-like Growth Factor 1 content in primary human lung tumours. Cancer Res 46: 985–988
Moses AC, Freinkel AJ, Knowles BB, et al (1983) Demonstration that a human hepatoma cell line produces a specific insulin-like growth factor carrier protein. J Clin Endocrinol Metab 56: 1003–1008
Ommaya AK, Rubin RC, Henderson ES, et al (1965) A new approach to the treatment of inoperable tumors. Med Ann DC 34: 455–458
Persson L, Boethius J, Gronowitz JS, et al (1985) Thymidine kinase in brain tumour cysts. J Neurosurg 63: 568–572
Rinderknecht E, Humbel RE (1978) Primary structure of human insulin-like growth factor II. FEBS lett 89: 283–286
Rinderknecht E, Humbel RE (1978) The aminoacid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 2253: 2769–2776
Sara VR, Hall K, Holst H von, et al (1982) Evidence for the presence of specific receptors for insulin-like growth factor II (IGF-1)1 and II (IGF-II) and insulin throughout the adult human brain. Neurosci Lett 34: 39–4
Sara VR, Hall K, Rodeck CH, et al (1981) Human embryonic somatomedm. Proc Natl Acad Sci USA 78: 3175–3179
Sara VR, Hall K (1984) The biosynthesis and regulation of fetal somatomedin. In: Ellendorff F, Gluckman PD, Parvizi N (eds) Fetal neuroendocrinology. Perinatology Press, New York, pp 213–229
Sara VR, Carlsson Skwirut C, Andersson C, et al (1986) Characterization of somatomedins from human fetal brain. Identification of a variant form of insulin-like growth factor I. Proc Natl Acad Sci USA 83: 4904–907
Sara VR, Prisell P, Sjögren B, Persson L, Boethius J, Enberg G (1986) Enhancement of insulin-like growth factor 2 receptors in glioblastoma. Cancer Lett 32: 229–234
Scott J, Cowell J, Robertson ME, et al (1985) Insulin-like growth factor-II gene expression in Wilm's tumour and embryonic tissues. Nature 317: 260–262
Seidenfeld J, Marton LJ (1979) Biochemical markers of central nervous system tumours measured in cerebrospinal fluid and their potential use in diagnosis and patient management: A review. J Natl Cancer Inst 63: 919–931
Todaro GJ, Larco JE de (1978) Growth factors produced by sarcoma virus-transformed cells. Cancer Res 38: 4147–4154
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prisell, P., Persson, L., Boethius, J. et al. Somatomedins in tumour cyst fluid, cerebrospinal fluid, and tumour cytosol in patients with glial tumours. Acta neurochir 89, 48–52 (1987). https://doi.org/10.1007/BF01406667
Issue Date:
DOI: https://doi.org/10.1007/BF01406667